Lille, France

Eric Van Belle

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Inserm (Institute National De La Santa Et De La Recherche Medicale), Instiut Pasteur De Lille. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Van Belle. Retrieved from https://idiyas.com/inventor/eric-van-belle-qkte3emv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Van Belle: Innovator in Aortic Valve Calcification Research

Introduction

Eric Van Belle is a notable inventor based in Lille, France. He has made significant contributions to the field of medical research, particularly in understanding and addressing aortic valve calcification. His innovative work has the potential to impact the treatment of heart conditions related to this ailment.

Latest Patents

Eric Van Belle holds a patent for the "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve." Aortic valve calcification is a condition characterized by calcium deposits forming on the aortic valve in the heart. These deposits can lead to narrowing at the opening of the aortic valve, resulting in a condition known as aortic valve stenosis. His research demonstrates that retinoic acid can decrease calcification and the osteoblast-like phenotype in valvular interstitial cells (VICs). More specifically, RARα activation has been shown to reduce calcification and the osteoblast-like phenotype in VIC. Conversely, inhibiting ALDH1A1 increases calcification and the osteoblast-like phenotype in VIC. These findings suggest that RAR agonists could be effective in reversing, preventing, or delaying aortic valve calcification.

Career Highlights

Throughout his career, Eric Van Belle has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Lille. His research has garnered attention for its innovative approach to aortic valve health and its implications for future treatments.

Collaborations

Eric has collaborated with notable colleagues, including Sophie Susen and Delphine Corseaux. Their combined expertise has contributed to advancing research in the field of cardiovascular health.

Conclusion

Eric Van Belle's work in the realm of aortic valve calcification represents a significant advancement in medical research. His innovative patent and collaborations highlight the importance of continued exploration in this critical area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…